Active Ingredient: CHLOROTHIAZIDE; RESERPINE
Proprietary Name: CHLOROTHIAZIDE AND RESERPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 250MG;0.125MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A088557
Product Number: 001
Approval Date: Dec 22, 1983
Applicant Holder Full Name: HIKMA PHARMACEUTICALS LLC
Marketing Status:
Discontinued
Patent and Exclusivity Information